Effects of tributyltin on the development of atopic dermatitis-like eruptions in DS-Nh mice

International Archives of Allergy and Immunology

Volumn 141, Issue 4, 2006, Pages 337-345

  Iwamura, Chiaki ^a   Aihara, Michiko ^a   Nakazawa, Masatoshi ^a   Takahashi, Kazuo ^a   Yoshioka, Naoya ^a   Matsukura, Setsuko ^a   Hirasawa, Tsutomu ^b   Minami, Mutsuhiko ^a   Ikezawa, Zenro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Atopic dermatitis; Endocrine disruptor; Staphylococcus aureus; Th1 Th2 balance

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; PICRYL CHLORIDE; STAPHYLOCOCCUS ENTEROTOXIN B; TRIBUTYLTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; LYMPHOCYTE CULTURE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SKIN SENSITIZATION; STAPHYLOCOCCUS AUREUS; SUPERNATANT; TH1 CELL; TH2 CELL;

ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; DRUG ERUPTIONS; FEMALE; MALE; MICE; PICRYL CHLORIDE; SKIN; STAPHYLOCOCCUS AUREUS; TH2 CELLS; TRIALKYLTIN COMPOUNDS;

EID: 33751231395     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095460     Document Type: Article

References (35)

1. Pastore S, Mascia F, Giustizieri ML, Gianetti A, Girolomoni G: Pathogenetic mechanisms of atopic dermatitis. Arch Immunol Ther Exp (Warsz) 2000;48:497-504.
2. Leung DYM: Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-876.
3. Romagnani S: The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399-408.
4. Akdis CA, Akdis M, Trautmann A, Blaser K: Immune regulation in atopic dermatitis. Curr Opin Immunol 2000;12:641-646.
5. Leung DYM: Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997;107:25-30.
6. Jujo K, Renz H, Abe J, Gelfand EW, Leung DYM: Decreased interferon gamma and increased interleukin-4 in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992;90:323-331.
7. Poulsen LK, Reimert CM, Bindslev-Jensen C, Hansen MB, Bendzen K: Biomolecular regulation of the IgE immune response. II. In vitro IgE synthesis and spontaneous production of cytokines. Int Arch Allergy Immunol 1995;106:55-61.
8. Leung DYM: Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-876.
9. Sekizawa J, Suter G, Birnbaum L: Tributyltin and Triphenyltin Compounds. Geneva, World Health Organization, 2001.
10. Bryan GW, Gibbs PE, Huggett RJ, Curtis LA, Bailey DS, Dauer DM: Effects of tributyltin pollution on the mud snail, Ilyanassa obsoleta, from the York River and Sarah Creek, Chesapeake Bay. Mar Pollut Bull 1989;20:458-462.
11. Oberdörster E, McClellan-Green P: Mechanisms of imposex induction in the mud snail, Ilyanassa obsoleta : TBT as a neurotoxin and aromatase inhibitor. Mar Environ Res 2002;54:715-718.
12. Ellis DV, Pattisina LA: Widespread neogastropod imposex: a biological indicator of global TBT contamination? Mar Pollut Bull 1990;21:248-253.
13. Krajnc EI, Wester PW, Loeber JG, van Leeuwen FXR, Vos JG, Vaessen HAMG, van der Heijden CA: Toxicity of bis(tri-n-butyltin) oxide in the rat. I. Short-term effects on general parameters and on the endocrine and lymphoid systems. Toxicol Appl Pharmacol 1984;75:363-386.
14. Snoeij NJ, Penninks AH, Seinen W: Biological activity of organotin compounds: an overview. Environ Res 1987;44:335-353.
15. Ishaaya I, Engel JL, Casida JE: Dietary triorganotins affect lymphatic tissues and blood composition of mice. Pestic Biochem Physiol 1976;6:270-279.
16. Haraguchi M, Hino M, Tanaka H, Maru M: Naturally occurring dermatitis associated with Staphylococcus aureus in DS- Nh mice. Exp Anim 1997;46:225-229.
17. Hikita I, Yoshioka T, Mizoguchi T, Tsukahara I, Tsuru K, Nagai H, Hirasawa T, Tsuruta Y, Suzuki R, Ichihashi M, Horikawa T: Characterization of dermatitis arising spontaneously in DS- Nh mice maintained under conventional conditions: another possible model for atopic dermatitis. J Dermatol Sci 2002;30:142-153.
18. Kitagaki H, Kimishima M, Teraki Y, Hayakawa J, Hayakawa K, Fujisawa S, Shiohara T: Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase. J Immunol 1999;163:1265-1273.
19. Matsukura S, Aihara M, Hirasawa T, Ikezawa Z: Effects of TNCB sensitization in DS-Nh mice serving as a model of atopic dermatitis, in comparison with NC/Nga mice. Int Arch Allergy Immunol 2005;136:173-180.
20. Cookson W: The alliance of genes and environment in asthma and allergy. Nature 1999;402:B5-B11.
21. Dobson S, Cabridenc R : Tributyltin Compounds. Environmental Health Criteria 116. Geneva, International Programme on Chemical Safety/World Health Organization, 1990.
22. Kannan K, Senthilkumar K, Giesy JP: Occurrence of butyltin compounds in human blood. Environ Sci Technol 1999;33:1776-1779.
23. Harino H, Fukushima M, Kawai S: Accumulation of butyltin and phenyltin compounds in various fish species. Arch Environ Contam Toxicol 2000;39:13-19.
24. Vos JG, de Klerk A, Krajnc EI, Kruizinga W, van Ommen B, Rozing J: Toxicity of bis(tri-n-butyltin)oxide in the rat. II. Suppression of thymus-dependent immune responses and of parameters of nonspecific resistance after short-term exposure. Toxicol Appl Pharmacol 1984;75:387-408.
25. Fong TAT, Mosmann TR: The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol 1989;143:2887-2893.
26. Seinen W, Vos JG, van Krieken R, Penninks A, Brands R, Hooykaas H: Toxicity of organotin compounds. III. Suppression of thymus-dependent immunity in rats by di-n-butyltinchloride and di-n-octyltindichloride. Toxicol Appl Pharmacol 1977;42:213-224.
27. Karpuzoglu-Sahin E, Zhi-Jun Y, Lengi A, Sriranganathan N, Ansar AS: Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine 2001;14:208-217.
28. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE: Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90:3730-3734.
29. Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzl S, Kreyden O, Disch R, Wüthrich B, Blaser K, Simon H-U: T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999;113:628-635.
30. Vos JG, De Klerk A, Krajnc EI, Van Loveren H, Rozing J: Immunotoxicity of bis(tri-n-butyltin) oxide in the rat: effects on thymus-dependent immunity and on nonspecific resistance following long-term exposure in young versus aged rats. Toxicol Appl Pharmacol 1990;105:144-155.
31. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DYM: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160.
32. Herz U, Bunikowski R, Renz H: Role of T cells in atopic dermatitis: new aspects on the dynamics of cytokine production and the contribution of bacterial superantigens. Int Arch Allergy Immunol 1998;115:179-190.
33. McFadden JP, Noble WC, Camp RDR: Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993;128:631-632.
34. Strickland I, Hauk PJ, Trumble AE, Picker LJ, Leung DYM: Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 1999;112:249-253.
35. Purwar R, Werfel T, Wittmann M: IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis. J Invest Dermatol 2006;126:1043-1051.